Homeo AI vs Simixa: Local Android Assistant or Review Copilot?

Quick answer

Choose Simixa when the immediate job is an Android-first homeopathy assistant that keeps case records on the device, structures case analysis, searches its literature through Smart Finder, tracks follow-ups and prescription history, and offers an optional backup path. Choose Homeo AI when the job begins with a completed case narrative and requires an inspectable review path through proposed symptoms, rubric mappings, linked source passages, remedy differentiation, and follow-up comparison.

Simixa's current Google Play listing limits the intended audience to qualified homeopathic practitioners and students under supervision. It describes the app as a clinical decision-support tool, not a diagnostic system or replacement for professional judgment. Homeo AI should be judged by the same practical boundary: a review copilot can make reasoning easier to inspect, but it cannot assume clinical responsibility.

There is no public Simixa price on the official pages reviewed on 8 August 2026. Its refund policy refers to subscriptions and credits, says purchases are generally non-refundable, and says unused credits do not expire. That is not enough to infer a price, billing cadence, included usage, or renewal term. Check the current in-app offer on the intended account and preserve a dated receipt or screenshot before purchasing.

What Simixa currently includes

The official Android listing describes structured case analysis, a Smart Finder for remedy and literature searches, local patient records, follow-up tracking, prescription history, and assisted export. It was updated on 3 May 2026 and showed more than 500 downloads when reviewed. The listing also says the app is available for Android and can be used in a desktop WebView environment.

The terms describe three core assistance functions: repertory analysis, AI-assisted case analysis, and Smart Finder search across homeopathic literature. They also identify patient case management as part of the service. Those are product claims a practitioner can turn into a controlled trial: enter the same case twice, inspect which symptoms are extracted, test a literature query, and see whether the follow-up preserves the earlier rationale.

The public pages do not establish which repertory editions, materia medica sources, model versions, or ranking rules are used for every output. They also do not publish independent clinical validation. A buyer should ask for the source catalogue and test whether a citation can be opened and verified rather than awarding credit for a plausible answer.

Where Simixa is genuinely strong

Its clearest advantage is a local-first mobile workflow. The privacy policy says patient case data is stored primarily in browser IndexedDB or user-selected local folders, depending on the environment. That can suit a solo practitioner who wants records close to the device rather than beginning with a cloud clinic system. Local storage still requires device security, operating-system updates, encrypted storage, screen-lock policy, backup discipline, and a tested recovery plan.

Simixa also combines records, analysis, search, and follow-up in one practitioner-facing interface. A clinic that currently moves between a notebook, a repertory, a separate search tool, and an ad hoc follow-up file may value that continuity. The Smart Finder proposition is especially testable: use a fixed set of known questions and record whether the returned passages are relevant, correctly attributed, and reproducible.

The vendor's policies provide more operational detail than a generic local-data slogan. They say some functions temporarily process information on server infrastructure and may use third-party AI providers such as OpenAI. They also describe user-controlled Google Drive backup, currently limited to Desktop WebView environments. Those statements do not complete a clinic's diligence, but they identify the exact boundaries that need testing.

How Homeo AI differs

Homeo AI is designed around an inspectable chain from narrative to review. The practitioner starts with a completed, de-identified case, examines how the narrative was interpreted, edits or rejects proposed symptoms and rubrics, opens linked source passages, compares remedy differences, and carries approved reasoning into follow-up.

That is a different emphasis from a mobile assistant with local records and an integrated Smart Finder. Simixa may be the more convenient fit when Android availability, device-local case continuity, prescription history, and one-screen lookup are decisive. Homeo AI may be the better fit when another practitioner needs to reconstruct why a phrase became a symptom, why a rubric was chosen, and what source passage supports a difference in the remedy review.

Neither product should receive credit for the other's capabilities. Homeo AI should not be described as providing Simixa's local Android record store or its exact Smart Finder catalogue. Simixa should not be assumed to preserve Homeo AI's exact narrative-to-rubric correction trail simply because it offers AI case analysis.

The local-data claim has an important boundary

Simixa's privacy policy says case records are stored locally, but it also says analysis, export, and AI-powered search may send the minimum data needed to remote infrastructure for temporary processing. It names third-party AI services as a possible part of that path. The terms likewise say limited case content may be transmitted temporarily when AI analysis is invoked.

That distinction matters. Local persistence does not mean every feature operates entirely offline or that no case text leaves the device. Before using real records, ask which exact fields each action transmits, which model provider receives them, where processing occurs, whether logs or abuse-monitoring copies remain, how deletion propagates, whether content is used for training or evaluation, and which contractual terms govern the transfer.

The policy describes optional Google Drive backup as user initiated and says Simixa does not retain those backup credentials. Confirm which record fields enter the backup, whether the file is independently encrypted, how restore behaves on a new device, and whether deleting a case also deletes prior backups. Test recovery before treating local storage as an operational advantage.

Until those answers satisfy clinic policy, use only completed, de-identified cases. Remove names, dates of birth, addresses, contact details, record numbers, photographs, rare locations, and combinations that could identify a person.

A reproducible clinic test

Prepare six completed, de-identified cases already reviewed by one practitioner. Include two straightforward cases, two close differentials, one follow-up, and one deliberately incomplete narrative. Add six known literature questions whose relevant passages have been checked in advance.

In Simixa, create each record, run structured analysis, inspect every symptom and suggested rubric, and use Smart Finder for the fixed questions. Record accepted and rejected suggestions, citation quality, correction time, export completeness, network activity, and whether a second device can recover the intended data. Add a follow-up and check whether prescription history and prior reasoning remain understandable. Repeat two cases after harmless wording changes and note unexplained variation.

In Homeo AI, enter the same de-identified narratives. Record every proposed symptom and rubric accepted, edited, or rejected. Open the linked passages, check whether the differential changes after corrections, and test whether follow-up preserves the earlier rationale.

Score both products on correction time, unsupported claims caught, source traceability, repeatability, export quality, backup recovery, data transmitted, and one-year cost at the clinic's actual case volume. Do not score agreement with a historical prescription as proof of correctness. A matching answer can still be produced for an unreviewable or mistaken reason.

Known limits and clinical responsibility

A local record does not establish confidentiality by itself. An AI literature result does not establish that the passage is correctly attributed or clinically applicable. An app update date and download count do not prove clinical accuracy. Simixa's own terms require the practitioner to independently verify output.

Homeo AI can also misinterpret a narrative, propose an unsuitable rubric, omit relevant evidence, or generate a plausible differential that needs correction. Inspectability helps expose work for review; it does not guarantee a correct conclusion.

Neither product replaces diagnosis, referral, an emergency-care decision, practitioner judgment, prescription, potency, dosage, or follow-up responsibility. Urgent symptoms require appropriate conventional assessment, not another software pass. The practitioner remains accountable for every accepted symptom, source, rubric, and clinical action.

Conditional verdict

Choose Simixa if Android access, local record persistence, prescription history, integrated Smart Finder, and a compact follow-up workflow are the priority, and if its written processing and backup boundaries satisfy clinic policy. Confirm the current in-app price and run a restore test before committing records to it.

Choose Homeo AI if the priority is a visible correction trail from a completed narrative to proposed rubrics, linked sources, remedy differentiation, and follow-up. If mobile recordkeeping and inspectable case review are both useful, test the products as complementary tools. The decision should follow measured checking time, source quality, data handling, recovery, export, and total cost, not the number of AI labels on a feature list.

Official sources checked

• Simixa official Google Play listing
• Simixa official privacy policy
• Simixa official terms and conditions
• Simixa official refund policy

Product facts reviewed 2026-08-08. Confirm current features, prices, source libraries, and terms with the vendor.